TOVX — THERIVA BIOLOGICS INC
As of Q2 2026, 7 SEC-registered investment managers reported holding TOVX (THERIVA BIOLOGICS INC) in their latest 13F filings, with a combined reported value of $136.28K across 544.74K shares. That is -24.7% by share count (-179.08K shares) versus the previous quarter, while reported value moved -3.9%. Ownership is concentrated: the five largest holders account for 95.8% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 3 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
TOVX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 294.02K | $73.56K | 0.00% | Reduce |
| Northern Trust Corp history | 82.70K | $20.69K | 0.00% | New |
| Renaissance Technologies history | 63.71K | $15.94K | 0.00% | New |
| UBS Group AG history | 61.05K | $15.26K | 0.00% | Reduce |
| Morgan Stanley history | 20.30K | $5.08K | 0.00% | Reduce |
| Two Sigma Investments history | 15.46K | $3.87K | 0.00% | Hold |
| BlackRock Inc history | 7.50K | $1.88K | 0.00% | Hold |
Q1 2026 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 450.26K | $88.16K | 0.00% | Add |
| UBS Group AG history | 225.62K | $44.22K | 0.00% | Add |
| Morgan Stanley history | 23.60K | $4.62K | 0.00% | Reduce |
| Two Sigma Investments history | 15.44K | $3.02K | 0.00% | Reduce |
| BlackRock Inc history | 7.50K | $1.47K | 0.00% | Hold |
| Citigroup Inc history | 1.39K | $272 | 0.00% | Reduce |
Q4 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 255.73K | $53.70K | 0.00% | Add |
| Geode Capital Management history | 212.09K | $44.62K | 0.00% | Add |
| Morgan Stanley history | 200.00K | $42.08K | 0.00% | New |
| UBS Group AG history | 191.41K | $40.20K | 0.00% | Add |
| Two Sigma Investments history | 42.34K | $8.91K | 0.00% | Reduce |
| Bank of America Corp history | 31.14K | $6.54K | 0.00% | Add |
| BlackRock Inc history | 7.50K | $1.58K | 0.00% | Hold |
| Citigroup Inc history | 6.19K | $1.30K | 0.00% | Add |
Q3 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Two Sigma Investments history | 61.84K | $25.05K | 0.00% | New |
| Geode Capital Management history | 28.21K | $11.43K | 0.00% | Add |
| UBS Group AG history | 22.91K | $9.28K | 0.00% | Add |
| Vanguard Group history | 16.38K | $6.63K | 0.00% | New |
| BlackRock Inc history | 7.51K | $3.04K | 0.00% | Reduce |
| Bank of America Corp history | 81 | $32 | 0.00% | Add |
| Citigroup Inc history | 1 | $0 | — | New |
Q2 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 36.02K | $15.62K | 0.00% | New |
| Geode Capital Management history | 18.60K | $8.07K | 0.00% | Hold |
| BlackRock Inc history | 7.57K | $3.28K | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | 3.00K | $1.30K | 0.00% | New |
| Bank of America Corp history | 74 | $32 | 0.00% | Add |
| UBS Group AG history | 1 | $0 | — | Reduce |
Q1 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 18.68K | $20.55K | 0.00% | New |
| UBS Group AG history | 7.85K | $8.64K | 0.00% | Reduce |
| BlackRock Inc history | 7.57K | $8.32K | 0.00% | Hold |
| Bank of America Corp history | 41 | $45 | 0.00% | Add |
New Positions (Q2 2026)
- Northern Trust Corp 82.70K sh · $20.69K
- Renaissance Technologies 63.71K sh · $15.94K
Fully Exited (vs previous quarter)
- Citigroup Inc sold 1.39K sh · $272
Fund Position History — shares by quarter (top 15 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 294.02K | 450.26K | 212.09K | 28.21K | 18.60K | 18.68K | — | — | 141.17K | 141.17K | 141.17K | 141.17K | 116.30K | 116.30K | 116.30K | 116.58K |
| Northern Trust Corp | 82.70K | — | — | — | — | — | — | — | 26.48K | 26.60K | 26.60K | 26.60K | 26.60K | 35.70K | 35.70K | 35.70K |
| Renaissance Technologies | 63.71K | — | — | — | — | — | — | — | 103.71K | 68.51K | 59.21K | 54.21K | 38.71K | 34.71K | 32.51K | 31.71K |
| UBS Group AG | 61.05K | 225.62K | 191.41K | 22.91K | 1 | 7.85K | 16.41K | 17.85K | 3 | 3 | 3 | — | 5.93K | — | 5.01K | 6.77K |
| Morgan Stanley | 20.30K | 23.60K | 200.00K | — | — | — | — | 20.20K | 15 | 15 | 515 | 10 | 12 | 10 | 671 | 298 |
| Two Sigma Investments | 15.46K | 15.44K | 42.34K | 61.84K | — | — | — | 13.57K | — | — | — | — | — | — | — | — |
| BlackRock Inc | 7.50K | 7.50K | 7.50K | 7.51K | 7.57K | 7.57K | 7.57K | 7.57K | — | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | 31.14K | 81 | 74 | 41 | 20 | 9 | 146 | 6 | 6 | 6 | 6 | 21 | 24 | 6 |
| Citigroup Inc | — | 1.39K | 6.19K | 1 | — | — | 7.76K | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | 255.73K | 16.38K | — | — | — | — | 194.49K | 225.27K | 366.58K | 512.76K | 525.37K | 525.37K | 525.37K | 525.09K |
| Citadel Advisors | — | — | — | — | 36.02K | — | — | — | — | 24.68K | 57.95K | — | — | 20.60K | — | 56.08K |
| Fidelity Management & Research (FMR) | — | — | — | — | 3.00K | — | — | — | 500 | 10 | 9 | 100 | — | — | 9 | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | — | 15 | — | — | — | — |
| Charles Schwab Investment Management | — | — | — | — | — | — | — | — | — | 13.57K | 13.57K | 13.57K | 13.57K | 13.57K | 13.57K | 13.57K |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | 100 | 233 | 231 | 124 | 109 | 110 | 108 | 105 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details